Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti-inflammatory drug presented as an injection for intramuscular use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions in adult patients.\n\nGNH India supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an oxicam‑class NSAID used to manage inflammatory musculoskeletal disorders.\n\nOsteoarthritis: reduces joint pain and improves functional ability.\nRheumatoid arthritis: alleviates synovial inflammation and joint swelling.\nAcute pain: provides short‑term relief of moderate to severe pain caused by injury or surgery.

Adverse reactions may occur with meloxicam injection.\n\nCommon Side Effects:\n- Injection‑site pain or erythema\n- Nausea or dyspepsia\n- Diarrhea\n- Dizziness\n\nSerious or Rare Side Effects:\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis\n- Severe hepatic injury\n- Anaphylactic or severe allergic reaction

Careful assessment and monitoring are required when using meloxicam injection.\n\nAssess renal function: adjust or avoid use in patients with significant renal impairment.\nMonitor hepatic enzymes: avoid in severe liver disease.\nEvaluate cardiovascular risk: use cautiously in patients with a history of thrombotic events.\nAvoid in known hypersensitivity to oxicams or other NSAIDs.\nUse the lowest effective dose for the shortest duration needed.\nStore at ambient temperature: keep in the original container, protect from moisture and light.

Meloxicam may interact with several medicines; monitoring or avoidance is advised.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): increased bleeding risk.\n- Lithium: elevated lithium serum concentrations.\n- Methotrexate: heightened toxicity.\n- ACE inhibitors or ARBs: possible reduction in renal function.\n\nModerate Interactions (Monitor Closely):\n- Diuretics: potential renal adverse effects.\n- SSRIs or SNRIs: additive bleeding tendency.\n- Cyclosporine: increased nephrotoxicity.